Docoh
Loading...

DXCM Dexcom

News

Pro users get this 30m faster
Benzinga's Top Ratings Upgrades, Downgrades For April 15, 2021
15 Apr 21
Upgrades, Downgrades, Initiation, Intraday Update, Analyst Ratings
Atlantic Equities Initiates Coverage On DexCom with Overweight Rating, Announces Price Target of $438
15 Apr 21
News, Price Target, Initiation, Analyst Ratings
Atlantic Equities initiates coverage on DexCom (NASDAQ:DXCM) with a Overweight rating and announces Price Target of $438.
Mid-Morning Market Update: US Stock Futures Trend Down; Nasdaq Composite Dips 0.2%
12 Feb 21
News, Penny Stocks, Eurozone, Commodities, Small Cap, Global, Markets
Following the market opening Friday, the Dow declined 0.09% to 31,402.67, while the NASDAQ fell 0.21% to 13,996.18. The S&P also plunged 0.05% to 3,914.51. Leading and Lagging Sectors
Citigroup Maintains Buy on DexCom, Lowers Price Target to $480
12 Feb 21
News, Price Target, Analyst Ratings
Citigroup analyst Joanne Wuensch maintains DexCom (NASDAQ:DXCM) with a Buy and lowers the price target from $485 to $480.
Morgan Stanley Maintains Equal-Weight on DexCom, Raises Price Target to $410
12 Feb 21
News, Price Target, Analyst Ratings
Morgan Stanley analyst David Lewis maintains DexCom (NASDAQ:DXCM) with a Equal-Weight and raises the price target from $402 to $410.
Raymond James Maintains Outperform on DexCom, Raises Price Target to $449
12 Feb 21
News, Price Target, Analyst Ratings
Raymond James analyst Jayson Bedford maintains DexCom (NASDAQ:DXCM) with a Outperform and raises the price target from $415 to $449.
12 Health Care Stocks Moving In Thursday's After-Market Session
11 Feb 21
Health Care, After-Hours Center, Movers, General
Gainers Intec Pharma (NASDAQ:NTEC) stock rose 7.5% to $7.16 during Thursday's after-market session. This security traded at a volume of 4.2K shares come close, making up 0.36% of its average volume over the last 100 days. The company's market cap stands at $28.2 million.
Recap: DexCom Q4 Earnings
11 Feb 21
Earnings
Shares of DexCom (NASDAQ:DXCM) moved lower in after-market trading after the company reported Q4 results. Quarterly Results Earnings per share fell 20.87% over the past year to $0.91, which missed the estimate of $0.92.
DexCom Q4 Adj. EPS $0.91 Misses $0.92 Estimate, Sales $568.90M Beat $552.23M Estimate
11 Feb 21
Earnings, News
DexCom (NASDAQ:DXCM) reported quarterly earnings of $0.91 per share which missed the analyst consensus estimate of $0.92 by 1.09 percent. This is a 20.87 percent decrease over earnings of $1.15 per share from the same
Earnings Scheduled For February 11, 2021
11 Feb 21
Earnings, News, Pre-Market Outlook, Markets
Companies Reporting Before The Bell • Bluerock Residential Growth REIT, Inc. Class A Common Stock (AMEX:BRG) is expected to report quarterly loss at $0.55 per share on revenue of $54.86 million.
Earnings Preview: DexCom
10 Feb 21
Earnings
On Thursday, February 11, DexCom (NASDAQ:DXCM) will release its latest earnings report. Decipher the announcement with Benzinga's help.
Nick Jonas, Bruce Springsteen, Scissorhands And More: Which Super Bowl Commercial Drew The Most Interest?
9 Feb 21
Sports, Media, General
Millions of fans tuned in to Super Bowl LV on Sunday to watch Tom Brady solidify his legacy as arguably the best quarterback of all time.
10 Health Care Stocks With Unusual Options Alerts In Today's Session
5 Feb 21
Health Care, Options, General
This unusual options alert can help traders discover the next big trading opportunities. Traders will search for circumstances when the market estimation of an option diverges heavily from its normal worth. Unusual trading activity could push option prices to exaggerated or underestimated levels.

Press releases

Pro users get this 30m faster
Manitoba and Saskatchewan Promise to Make Life-Changing Dexcom G6 CGM System Accessible for Children and Young Adults with Type 1 Diabetes
16 Apr 21
Press Releases
Dexcom G6 gives people with diabetes the power to manage their condition without fingersticks* or scanning BURNABY, BC, April 16, 2021 /CNW/ - Dexcom, Inc. (NASDAQ:DXCM), a leader in real-time continuous glucose
Dexcom Schedules First Quarter 2021 Earnings Release and Conference Call for April 29, 2021 at 4:30 p.m. Eastern Time
1 Apr 21
Press Releases
DexCom, Inc. (NASDAQ:DXCM) today announced that it plans to release its first quarter 2021 financial results after market close on Thursday, April 29, 2021. Management will hold a conference call to review the
Dexcom Promotes Jereme Sylvain to Chief Financial Officer
23 Mar 21
Press Releases
DexCom, Inc. (NASDAQ:DXCM), the global leader in real-time continuous glucose monitoring, today announced the promotion of Jereme Sylvain to the role of Executive Vice President and Chief Financial Officer. In his
Dexcom Announces Upcoming Virtual Conference Presentations
17 Feb 21
Press Releases
DexCom, Inc. (NASDAQ:DXCM) today announced that management will present an update on the company at the following upcoming virtual investor conferences: Quentin Blackford, Chief Operating Officer and Chief Financial
Dexcom Launches Inaugural Venture Capital Fund
11 Feb 21
Press Releases
Dexcom Ventures to identify and invest in transformational technologies to advance long-term growth DexCom, Inc. (NASDAQ:DXCM), the global leader in continuous glucose monitoring for people with diabetes, today
Dexcom Reports Fourth Quarter and Fiscal Year 2020 Financial Results
11 Feb 21
Press Releases
DexCom, Inc. (NASDAQ:DXCM) today reported its financial results as of and for the quarter and fiscal year ended December 31, 2020. Fourth Quarter 2020 Financial Highlights: Revenue grew 23% versus the same quarter of
DexCom, Inc. to Host Earnings Call
11 Feb 21
Earnings, News, Press Releases
NEW YORK, NY / ACCESSWIRE / February 11, 2021 / DexCom, Inc. (NASDAQ:DXCM) will be discussing their earnings results in their 2020 Fourth Quarter Earnings call to be held on February 11, 2021 at 4:30 PM Eastern Time.To
Dexcom and Nick Jonas Unveil First-Ever Super Bowl Commercial, Calling for Better Care for People With Diabetes
2 Feb 21
Press Releases
Partnership brings important diabetes conversation to one of the world's biggest stages Ad raises awareness of Dexcom continuous glucose monitoring as newer, better technology replacing painful fingerpricks In the
Dexcom Schedules Fourth Quarter and Full Year 2020 Earnings Release and Conference Call for February 11, 2021 at 4:30 p.m. Eastern Time
19 Jan 21
Press Releases
DexCom, Inc. (NASDAQ:DXCM) today announced that it plans to release its fourth quarter and full year 2020 financial results after market close on Thursday, February 11, 2020. Management will hold a conference call to